ZBRA — Zebra Technologies Corporation

Q2 2026 (period ended Jul 4) crushed estimates: revenue rose 20.4% YoY to $1.557B, non-GAAP EPS of $6.35 was well above the ~$4.36 consensus, adjusted gross margin expanded 540 bps, and management raised FY2026 sales growth to 14-16% and EPS to $20.75-$21.25. Follow-on analyst target hikes and aggressive buybacks have made the tape decisively bullish.

The three-year trend is a textbook cyclical inflection. Revenue bottomed around $956M in Sep 2023, was roughly flat-to-mid-single-digit through 2025, and re-accelerated to +14.3% YoY in Q1 2026 and +20.4% YoY in Q2 2026. Operating margin expanded from -1.3% in Sep 2023 to 20.6% in Q2 2026 (321M operating income on 1.557B revenue), versus 14.2% a year earlier. Net income in Q4 2025 was depressed to $70M by charges, but operating income was a healthy $222M, so that quarter was a blip, not a trend reversal. FCF has also inflected, from -49M in 2023 to 198M in Q2 2026 and roughly 904M over the last four reported quarters, with FY guidance above $1B.

As of 2026-08-27, trailing GAAP P/E is 33.8x on EPS of $10.70, but that is misleading because it uses GAAP earnings depressed by charges and non-GAAP adjustments. On FY2026 consensus non-GAAP EPS of $21.125, the forward P/E is about 17.1x. P/S of 2.94x sits below the 5-year average of 3.46x. The TTM PEG of 120 is not meaningful. The stock is not cheap on GAAP earnings, but it is reasonable-to-attractive on forward earnings and slightly below its own sales multiple history.

At $361, the market is paying roughly 17x expected 2026 earnings, not a premium multiple, so the rally is mostly 'earnings catching up with price' rather than excessive multiple expansion. The stock is effectively asking management to deliver the raised 14-16% sales growth and $20.75-$21.25 EPS. If Q3, due Nov 3, comes with another raise, estimates will move up further; if memory-cost pressure or a retail/logistics slowdown bites, the forward multiple could compress toward 15x.

As of 2026-08-27, RSI was 62.79, just below overbought, and price was essentially flat versus the 20-day SMA (-0.04%), but 19.89% above the 50-day and 42.14% above the 200-day. That is a strong uptrend with short-term consolidation. The cleanest entry points would be a pullback toward the 50-day (~$301) or a confirmed breakout above the 52-week high of $386.23; chasing at 42% above the 200-day carries higher timing risk.

• Memory component costs are a ~$120M headwind; mitigation comes from pricing and 18-month supplier commitments, but input inflation remains the biggest near-term margin risk.
• Frontline AI, machine vision, and RFID adoption are driving secular demand from retail, logistics, and manufacturing customers.
• High beta of 1.58 means ZBRA is more exposed to tech-sector rotation and swings in Treasury yields.
• Tariffs/IEEPA recoveries contributed $73M in 2026, so changes in tariff policy could swing results.
• Retail and logistics end-markets are cyclical; a broader macro slowdown would hurt order momentum.

• Q3 2026 earnings on November 3, 2026 - another guidance raise would support the bull case.
• Remaining share repurchase execution under the $700M annual program.
• Continued adoption of RFID/machine vision/frontline AI and related software/services attach.
• Additional analyst price-target increases after the Q2 beat.

• Memory/components cost inflation and/or inability to keep passing through prices.
• Cyclical slowdown in retail, logistics, and manufacturing capex.
• Valuation/technical risk after a 42% run above the 200-day; high beta cuts both ways.
• Weak current ratio (0.52x at Q2 2026) and a large swing in current liabilities/long-term debt, so liquidity and refinancing deserve monitoring despite 1.9x net leverage and strong FCF.
• GAAP-to-non-GAAP gap is large; if charge levels normalize, reported earnings should catch up, but until then, forward EPS relies on adjusted definitions.

Zebra is a good risk/reward right now: it is a cyclical recovery story with accelerating revenue, expanding operating margins, record free cash flow, a raised FY2026 outlook, and a reasonable ~17x forward multiple. The main caveats are input-cost inflation and a high-beta cyclical end-market, but on the current data the weight of evidence is positive.

Applied a 19.5x multiple to FY2026 consensus non-GAAP EPS of $21.125, yielding $412; the multiple is a middle ground justified by 14-16% revenue growth, margin expansion, and >$1B expected FCF, discounted for cyclicality and component-cost risk.